Xylyx Bio, Inc.

Xylyx Bio, Inc. Xylyx Bio offers tissue-specific ECM substrates, clinically relevant data packages, and compound tes

Xylyx Bio's mission is to increase predictiveness and confidence in drug discovery for cancer, fibrosis, and other devastating diseases through our physiologically-relevant IN MATRICO™ platform. Our platform technology incorporates human tissue and disease-specific extracellular matrix substrates combined with clinically relevant data packages to enable drug candidates to be tested IN MATRICO™ to inform better decision making in drug discovery. Tissue-specific ECM substrates enable high-fidelity disease models that reflect human disease biology and are provided in both 2D and 3D product formats that are compatible with low and high throughput screening. Xylyx Bio also offers IN MATRICO™ compound testing services to accurately predict in-vivo drug response.

Address

760 Parkside Avenue
New York, NY
11226

Alerts

Be the first to know and let us send you an email when Xylyx Bio, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Xylyx Bio, Inc.:

Shortcuts

Share